Arnold-Chiari malformation
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: : Fahimeh Shojaei, M.D.
Synonyms and keywords: Chiari malformation; ACM.
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Historical Perspective
Arnold-Chiari malformation was first described by Cleland in 1883 in a child with spina bifida. Hans Chiari, an Austrian pathologist was the first person who described type 2 Arnold-Chiari malformation. Hans Chiari also described different classification of Arnold-Chiari malformation into 4 groups.
Classification
Arnold chiari malformation may be classified according to herniation content into 4 subtypes. Type 1 has herniation of cerebellar tonsils. Type 2 has herniation of cerebellar tonsils and vermis. Type 3 has herniation of cerebellar tonsil and vermis and lower brain stem. Type 4 has cerebellar hypoplasia with brain stem in posterior fossa.
Pathophysiology
The exact pathogenesis of Arnol-Chiari malformation is not fully understood but It is thought that Arnol-Chiari malformation is the result of bone developmental abnormalities or mesodermal growth and differentiation abnormalities. Genes involved in the pathogenesis of Arnold-Chiari malformation include PAX1, PAX2, PAX3, PAX6, FGF2, TBX6, HOX gene, Noggin gene, and EFNB1. Conditions associated with Arnold-Chiari malformation include hydrocephalus, syringomyelias,Tethered spinal cord syndrome, neurofibromatosis type 1, Noonan syndrome, Pierre Robin sequence, Klippel-Feil syndrome, Albright hereditary osteodystrophy, x-linked aqueductal stenosis, Goldenhar syndrome, Williams syndrome, Shprintzen- goldberg syndrome, achondroplasia, familial osteosclerosis, velocardiofacial syndrome, and connective tissue disorders.
Causes
The cause of Arnold Chiari malformation include craniosynostosis, osteopetrosis, vitamin D deficiency and genetic mutations.
Differentiating Arnold-Chiari malformation from Other Diseases
On the basis of seizure, visual disturbance, and constitutional symptoms, Arnold-Chiari malformation must be differentiated from astrocytoma, oligodendroglioma, meningioma, hemangioblastoma, pituitary adenoma, schwannoma, primary CNS lymphoma, medulloblastoma, ependymoma, craniopharyngioma, pinealoma, AV malformation, brain aneurysm, bacterial brain abscess, tuberculosis, toxoplasmosis, hydatid cyst, CNS cryptococcosis, CNS aspergillosis, and brain metastasis.
Epidemiology and Demographics
The prevalence of Arnold Chiari malformation is unknown since most of the cases are accidentally found. The mortality rate of Arnold Chiari malformation depends on the subtype but type 3 has the highest mortality rate as a result of respiratory failure in infancy. Arnold Chiari malformation commonly affects adolescence and adulthood, but also has been seen in younger children. There is no racial predilection to Arnold Chiari malformation.
Risk Factors
Common risk factors in the development of Arnold-Chiari malformation include lumbar-peritoneal shunt and multiple lumbar puncture.
Screening
There is insufficient evidence to recommend routine screening for Arnold-Chiari malformation.
Natural History, Complications, and Prognosis
Diagnosis
Diagnostic Study of Choice
MRI is the gold standard test for the diagnosis of Arnold Chiari malformation. Cerebellar tonsillar herniation, wedge shaped tonsils, syringohydromyelia, small posterior fossa, obstructive hydrocephalus, and brainstem anomalies.
History and Symptoms
Patients with Arnold-Chiari malformation may have a positive history of lumbar puncture, lumbar-peritoneal shunt, hydrocephalus, syringomyelias,Tethered spinal cord syndrome, neurofibromatosis type 1, Noonan syndrome, Pierre Robin sequence, Klippel-Feil syndrome, Albright hereditary osteodystrophy, x-linked aqueductal stenosis, Goldenhar syndrome, Williams syndrome, Shprintzen- goldberg syndrome, achondroplasia, familial osteosclerosis, velocardiofacial syndrome, and connective tissue disorders. The most common symptoms of Arnold-Chiari malformation is headache, arm pain and weakness, neck pain, nausea and vomiting, balance problem, dizziness and ear ringing.
Physical Examination
Patients with Arnold Chiari malformation usually appear normal. Physical examination of patients with Arnold Chiari malformation is usually remarkable for impaired coordination, sensory/ motor deficit, abnormal gait, nystagmus, scoliosis, and autonomic dysfunction.
Laboratory Findings
There are no diagnostic laboratory findings associated with Arnold Chiari malformation.
Electrocardiogram
There are no ECG findings associated with Arnold Chiari malformation.
X-ray
Ultrasound
There are no ultrasound findings associated with Arnold-Chiari malformation.
CT scan
CT scan may be helpful in the diagnosis of Arnold Chiari malformation. Findings on CT scan diagnostic of Arnold Chiari malformation depends on the subtype and include herniation of cerebellar tonsils, vermis, and lower brain stem, underdeveloped cerebellum and crowded foramen magnum.
MRI
MRI may be helpful in the diagnosis of Arnold-Chiari malformation. Findings on MRI diagnostic of Arnold-Chiari malformation include cerebellar tonsillar herniation, wedge shaped tonsils, syringohydromyelia, small posterior fossa, obstructive hydrocephalus, and brainstem anomalies.
Other Imaging Findings
There are no other imaging findings associated with Arnold-Chiari malformation.
Other Diagnostic Studies
There are no other diagnostic studies associated with Arnold-Chiari malformation.
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
There are no established measures for the primary prevention of Arnold-Chiari malformation.
Secondary Prevention
There are no established measures for the secondary prevention of Arnold-Chiari malformation.
References
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Arnold-Chiari malformation was first described by Cleland in 1883 in a child with spina bifida. Hans Chiari, an Austrian pathologist was the first person who described type 2 Arnold-Chiari malformation. Hans Chiari also described different classification of Arnold-Chiari malformation into 4 groups.
Historical Perspective
Discovery
- Arnold-Chiari malformation was first discribed by Cleland in 1883 in a child with spina bifida.[1]
- Hans Chiari, an Austrian pathologist and Julius Arnold (1835-1915), professor of anatomy at Heidelberg first described Arnold-Chiari malformation.
- Hans Chiari also described different classification of Arnold-Chiari malformation into 4 groups.
References
- ↑ Loukas, Marios; Noordeh, Nima; Shoja, Mohammadali M.; Pugh, Jeffrey; Oakes, W. Jerry; Tubbs, R. Shane (2007). “Hans Chiari (1851–1916)”. Child’s Nervous System. 24 (3): 407–409. doi:10.1007/s00381-007-0535-y. ISSN 0256-7040.
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Arnold chiari malformation may be classified according to herniation content into 4 subtypes. Type 1 has herniation of cerebellar tonsils. Type 2 has herniation of cerebellar tonsils and vermis. Type 3 has herniation of cerebellar tonsil and vermis and lower brain stem. Type 4 has cerebellar hypoplasia with brain stem in posterior fossa.
Classification
Arnold chiari malformation may be classified according to herniation content into 4 subtypes:[1]
| Subtypes | Explanation | Association |
|---|---|---|
| Type1 | Herniation parts: Cerebellar tonsils
|
Syringomyelia |
| Type 2 | Herniation parts: Cerebellar tonsils and vermis
|
Lumbosacral myelomeningocele |
| Type 3 | Herniation parts: Cerebellar tonsil and vermis, lower brain stem
|
Occipital encephalocele |
| Type 4 | Herniation parts: Brain stem located in posterior fossa, underdeveloped cerebellum
|
A variation of cerebellar hypoplasia |
References
- ↑ Cotes C, Bonfante E, Lazor J, Jadhav S, Caldas M, Swischuk L, Riascos R (June 2015). “Congenital basis of posterior fossa anomalies”. Neuroradiol J. 28 (3): 238–53. doi:10.1177/1971400915576665. PMC 4757284. PMID 26246090.
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
The exact pathogenesis of Arnol-Chiari malformation is not fully understood but It is thought that Arnol-Chiari malformation is the result of bone developmental abnormalities or mesodermal growth and differentiation abnormalities. Genes involved in the pathogenesis of Arnold-Chiari malformation include PAX1, PAX2, PAX3, PAX6, FGF2, TBX6, HOX gene, Noggin gene, and EFNB1. Conditions associated with Arnold-Chiari malformation include hydrocephalus, syringomyelias,Tethered spinal cord syndrome, neurofibromatosis type 1, Noonan syndrome, Pierre Robin sequence, Klippel-Feil syndrome, Albright hereditary osteodystrophy, x-linked aqueductal stenosis, Goldenhar syndrome, Williams syndrome, Shprintzen- goldberg syndrome, achondroplasia, familial osteosclerosis, velocardiofacial syndrome, and connective tissue disorders.
Pathophysiology
Pathogenesis
- The exact pathogenesis of Arnol-Chiari malformation is not fully understood but It is thought that Arnol-Chiari malformation is the result of cascade of anomalies that lead to:
- Bone developmental abnormalities
- Mesodermal growth and differentiation abnormalities
- These anomalies can be congenital as a result of developmental error or acquired.
- All the potential causes of Chiari malformation will lead to posterior cranial fossa abnormalities and subsequently herniation of cerebellar and/or other structures from foramen magnum.
Genetics
- Genes involved in the pathogenesis of Arnold-Chiari malformation include:[1]
- There are many findings emphasizing on genetic basic of Chiari malformation including:
- Many studies described higher prevalence of Chiari malformation among mono zygote twins or between family members.
- There are some evidence showing autosomal dominant/ recessive transmission.
- There are many genetic conditions that have association with Chiari malformation.
Associated Conditions
Conditions associated with Arnold-Chiari malformation include:[2][3][4][5][6][7]
- Hydrocephalus
- Syringomyelias
- Tethered spinal cord syndrome
- Neurofibromatosis type 1
- Noonan syndrome
- Pierre Robin sequence
- Klippel-Feil syndrome
- Albright hereditary osteodystrophy
- X-linked aqueductal stenosis
- Goldenhar syndrome
- Williams syndrome
- Shprintzen- goldberg syndrome
- Achondroplasia
- Familial osteosclerosis
- Velocardiofacial syndrome
- Connective tissue disorders such as:
Gross Pathology
On gross pathology, there is no characteristic finding of Chiari malfromation.
Microscopic Pathology
On microscopic pathology, there is enlaged, dysplastic / reactive fibrous tissue and choroid plexus in a Chiari II malformation.


References
- ↑ Schanker, Benjamin D.; Walcott, Brian P.; Nahed, Brian V.; Kahle, Kristopher T.; Li, Yan Michael; Coumans, Jean-Valery C. E. (2011). “Familial Chiari malformation: case series”. Neurosurgical Focus. 31 (3): E1. doi:10.3171/2011.6.FOCUS11104. ISSN 1092-0684.
- ↑ “Neuropathology For Medical Students”.
- ↑ Milhorat TH, Bolognese PA, Nishikawa M, McDonnell NB, Francomano CA (2007). “Syndrome of occipitoatlantoaxial hypermobility, cranial settling, and chiari malformation type I in patients with hereditary disorders of connective tissue”. Journal of Neurosurgery: Spine. 7 (6): 601–9. doi:10.3171/SPI-07/12/601. PMID 18074684. Unknown parameter
|month=ignored (help) - ↑ Holder-Espinasse M, Abadie V, Cormier-Daire V, Beyler C, Manach Y, Munnich A, Lyonnet S, Couly G, Amiel J (October 2001). “Pierre Robin sequence: a series of 117 consecutive cases”. J. Pediatr. 139 (4): 588–90. doi:10.1067/mpd.2001.117784. PMID 11598609.
- ↑ Tubbs RS, Rutledge SL, Kosentka A, Bartolucci AA, Oakes WJ (April 2004). “Chiari I malformation and neurofibromatosis type 1”. Pediatr. Neurol. 30 (4): 278–80. doi:10.1016/j.pediatrneurol.2003.09.013. PMID 15087107.
- ↑ Schanker, Benjamin D.; Walcott, Brian P.; Nahed, Brian V.; Kahle, Kristopher T.; Li, Yan Michael; Coumans, Jean-Valery C. E. (2011). “Familial Chiari malformation: case series”. Neurosurgical Focus. 31 (3): E1. doi:10.3171/2011.6.FOCUS11104. ISSN 1092-0684.
- ↑ Holder-Espinasse M, Winter RM (October 2003). “Type 1 Arnold-Chiari malformation and Noonan syndrome. A new diagnostic feature?”. Clin. Dysmorphol. 12 (4): 275. doi:10.1097/01.mcd.0000081505.97834.0a. PMID 14564218.
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
The cause of Arnold Chiari malformation include craniosynostosis, osteopetrosis, vitamin D deficiency and genetic mutations.
Causes
Common Causes
Common causes of Arnold Chiari malformation may include:[1][2][3]
Less Common Causes
Less common causes of Arnold Chiari malformation include:
Genetic Causes
Arnold Chiari malformation is caused by a mutation in following genes:[4]
References
- ↑ Kuether, Todd A.; Piatt, Joseph H. (1998). “Chiari Malformation Associated with Vitamin D-resistant Rickets: Case Report”. Neurosurgery. 42 (5): 1168–1171. doi:10.1097/00006123-199805000-00134. ISSN 0148-396X.
- ↑ Cinalli, Giuseppe; Spennato, Pietro; Sainte-Rose, Christian; Arnaud, Eric; Aliberti, Ferdinando; Brunelle, Francis; Cianciulli, Emilio; Renier, Dominique (2005). “Chiari malformation in craniosynostosis”. Child’s Nervous System. 21 (10): 889–901. doi:10.1007/s00381-004-1115-z. ISSN 0256-7040.
- ↑ Dlouhy, Brian J.; Menezes, Arnold H. (2011). “Osteopetrosis with Chiari I malformation: presentation and surgical management”. Journal of Neurosurgery: Pediatrics. 7 (4): 369–374. doi:10.3171/2011.1.PEDS10353. ISSN 1933-0707.
- ↑ Schanker, Benjamin D.; Walcott, Brian P.; Nahed, Brian V.; Kahle, Kristopher T.; Li, Yan Michael; Coumans, Jean-Valery C. E. (2011). “Familial Chiari malformation: case series”. Neurosurgical Focus. 31 (3): E1. doi:10.3171/2011.6.FOCUS11104. ISSN 1092-0684.
Differentiating Arnold-Chiari malformation from other Diseases

For the WikiDoc page for this topic, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
On the basis of seizure, visual disturbance, and constitutional symptoms, Arnold-Chiari malformation must be differentiated from astrocytoma, oligodendroglioma, meningioma, hemangioblastoma, pituitary adenoma, schwannoma, primary CNS lymphoma, medulloblastoma, ependymoma, craniopharyngioma, pinealoma, AV malformation, brain aneurysm, bacterial brain abscess, tuberculosis, toxoplasmosis, hydatid cyst, CNS cryptococcosis, CNS aspergillosis, and brain metastasis.
Differentiating Arnold-Chiari malformation from other Diseases
Differentiating Arnold-Chiari malformation from other diseases on the basis of seizure, visual disturbance, and constitutional symptoms
On the basis of seizure, visual disturbance, and constitutional symptoms, Arnold-Chiari malformation must be differentiated from astrocytoma, oligodendroglioma, meningioma, hemangioblastoma, pituitary adenoma, schwannoma, primary CNS lymphoma, medulloblastoma, ependymoma, craniopharyngioma, pinealoma, AV malformation, brain aneurysm, bacterial brain abscess, tuberculosis, toxoplasmosis, hydatid cyst, CNS cryptococcosis, CNS aspergillosis, and brain metastasis.
| Diseases | Clinical manifestations | Para-clinical findings | Gold standard |
Additional findings | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Symptoms | Physical examination | |||||||||
| Lab Findings | MRI | Immunohistopathology | ||||||||
| Head- ache |
Seizure | Visual disturbance | Constitutional | Focal neurological deficit | ||||||
| Other | ||||||||||
| Arnold-Chiari malformation [1][2][3] | + | + | + | − | + | − |
|
|
| |
| Brain metastasis [4][5] |
+ | +/− | +/− | + | + | − |
|
|
|
|
| Adult primary brain tumors | ||||||||||
| Glioblastoma multiforme [6][7][5] |
+ | +/− | +/− | − | + | − |
|
|
| |
| Oligodendroglioma [8][9][10] |
+ | + | +/− | − | + | − |
|
|
| |
| Meningioma [11][12][13] |
+ | +/− | +/− | − | + | − |
|
|
| |
| Hemangioblastoma [14][15][16][17] |
+ | +/− | +/− | − | + | − |
|
| ||
| Pituitary adenoma [18][19][5] |
− | − | + Bitemporal hemianopia | − | − |
|
|
|
| |
| Schwannoma [20][21][22][23] |
− | − | − | − | + | − |
|
|
| |
| Primary CNS lymphoma [24][25] |
+ | +/− | +/− | − | + | − |
|
|
| |
| Childhood primary brain tumors | ||||||||||
| Pilocytic astrocytoma [26][27][28] |
+ | +/− | +/− | − | + | − |
|
|
| |
| Medulloblastoma [29][30][31] |
+ | +/− | +/− | − | + | − |
|
|
| |
| Ependymoma [32][5] |
+ | +/− | +/− | − | + | − |
|
|
| |
| Craniopharyngioma [33][34][35][5] |
+ | +/− | + Bitemporal hemianopia | − | + |
|
|
|
| |
| Pinealoma [36][37][38] |
+ | +/− | +/− | − | + vertical gaze palsy |
|
|
|
| |
| Vascular | ||||||||||
| AV malformation [39][40][5] |
+ | + | +/− | − | +/− | − |
|
| ||
| Brain aneurysm [41][42][43][44][45] |
+ | +/− | +/− | − | +/− | − |
|
|
|
|
| Infectious | ||||||||||
| Bacterial brain abscess [46][47] |
+ | +/− | +/− | + | + |
|
|
|
|
|
| Tuberculosis [48][5][49] |
+ | +/− | +/− | + | + |
|
|
|
|
|
| Toxoplasmosis [50][51] |
+ | +/− | +/− | − | + |
|
|
|
|
|
| Hydatid cyst [52][5] |
+ | +/− | +/− | +/− | + |
|
|
|
|
|
| CNS cryptococcosis [53] |
+ | +/− | +/− | + | + |
|
|
|
|
|
| CNS aspergillosis [54] |
+ | +/− | +/− | + | + |
|
|
|
|
|
ABBREVIATIONS
CNS=Central nervous system, AV=Arteriovenous, CSF=Cerebrospinal fluid, NF-2=Neurofibromatosis type 2, MEN-1=Multiple endocrine neoplasia, GFAP=Glial fibrillary acidic protein, HIV=Human immunodeficiency virus, BhCG=Human chorionic gonadotropin, ESR=Erythrocyte sedimentation rate, AFB=Acid fast bacilli, MRA=Magnetic resonance angiography, CTA=CT angiography
References
- ↑ “Neuropathology For Medical Students”.
- ↑ Milhorat TH, Bolognese PA, Nishikawa M, McDonnell NB, Francomano CA (2007). “Syndrome of occipitoatlantoaxial hypermobility, cranial settling, and chiari malformation type I in patients with hereditary disorders of connective tissue”. Journal of Neurosurgery: Spine. 7 (6): 601–9. doi:10.3171/SPI-07/12/601. PMID 18074684. Unknown parameter
|month=ignored (help) - ↑ Meadows, Jeffery; Kraut, Michael; Guarnieri, Michael; Haroun, Raymond I.; Carson, Benjamin S. (2000). “Asymptomatic Chiari Type I malformations identified on magnetic resonance imaging”. Journal of Neurosurgery. 92 (6): 920–926. doi:10.3171/jns.2000.92.6.0920. ISSN 0022-3085.
- ↑ Pope WB (2018). “Brain metastases: neuroimaging”. Handb Clin Neurol. 149: 89–112. doi:10.1016/B978-0-12-811161-1.00007-4. PMC 6118134. PMID 29307364.
- ↑ 5.0 5.1 5.2 5.3 5.4 5.5 5.6 5.7 Mattle, Heinrich (2017). Fundamentals of neurology : an illustrated guide. Stuttgart New York: Thieme. ISBN 9783131364524.
- ↑ Sathornsumetee S, Rich JN, Reardon DA (November 2007). “Diagnosis and treatment of high-grade astrocytoma”. Neurol Clin. 25 (4): 1111–39, x. doi:10.1016/j.ncl.2007.07.004. PMID 17964028.
- ↑ Pedersen CL, Romner B (January 2013). “Current treatment of low grade astrocytoma: a review”. Clin Neurol Neurosurg. 115 (1): 1–8. doi:10.1016/j.clineuro.2012.07.002. PMID 22819718.
- ↑ Smits M (2016). “Imaging of oligodendroglioma”. Br J Radiol. 89 (1060): 20150857. doi:10.1259/bjr.20150857. PMC 4846213. PMID 26849038.
- ↑ Wesseling P, van den Bent M, Perry A (June 2015). “Oligodendroglioma: pathology, molecular mechanisms and markers”. Acta Neuropathol. 129 (6): 809–27. doi:10.1007/s00401-015-1424-1. PMC 4436696. PMID 25943885.
- ↑ Kerkhof M, Benit C, Duran-Pena A, Vecht CJ (2015). “Seizures in oligodendroglial tumors”. CNS Oncol. 4 (5): 347–56. doi:10.2217/cns.15.29. PMC 6082346. PMID 26478444.
- ↑ Zee CS, Chin T, Segall HD, Destian S, Ahmadi J (June 1992). “Magnetic resonance imaging of meningiomas”. Semin. Ultrasound CT MR. 13 (3): 154–69. PMID 1642904.
- ↑ Shibuya M (2015). “Pathology and molecular genetics of meningioma: recent advances”. Neurol. Med. Chir. (Tokyo). 55 (1): 14–27. doi:10.2176/nmc.ra.2014-0233. PMID 25744347.
- ↑ Begnami MD, Palau M, Rushing EJ, Santi M, Quezado M (September 2007). “Evaluation of NF2 gene deletion in sporadic schwannomas, meningiomas, and ependymomas by chromogenic in situ hybridization”. Hum. Pathol. 38 (9): 1345–50. doi:10.1016/j.humpath.2007.01.027. PMC 2094208. PMID 17509660.
- ↑ Lonser RR, Butman JA, Huntoon K, Asthagiri AR, Wu T, Bakhtian KD, Chew EY, Zhuang Z, Linehan WM, Oldfield EH (May 2014). “Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease”. J. Neurosurg. 120 (5): 1055–62. doi:10.3171/2014.1.JNS131431. PMC 4762041. PMID 24579662.
- ↑ Hussein MR (October 2007). “Central nervous system capillary haemangioblastoma: the pathologist’s viewpoint”. Int J Exp Pathol. 88 (5): 311–24. doi:10.1111/j.1365-2613.2007.00535.x. PMC 2517334. PMID 17877533.
- ↑ Lee SR, Sanches J, Mark AS, Dillon WP, Norman D, Newton TH (May 1989). “Posterior fossa hemangioblastomas: MR imaging”. Radiology. 171 (2): 463–8. doi:10.1148/radiology.171.2.2704812. PMID 2704812.
- ↑ Perks WH, Cross JN, Sivapragasam S, Johnson P (March 1976). “Supratentorial haemangioblastoma with polycythaemia”. J. Neurol. Neurosurg. Psychiatry. 39 (3): 218–20. PMID 945331.
- ↑ Kucharczyk W, Davis DO, Kelly WM, Sze G, Norman D, Newton TH (December 1986). “Pituitary adenomas: high-resolution MR imaging at 1.5 T”. Radiology. 161 (3): 761–5. doi:10.1148/radiology.161.3.3786729. PMID 3786729.
- ↑ Syro LV, Scheithauer BW, Kovacs K, Toledo RA, Londoño FJ, Ortiz LD, Rotondo F, Horvath E, Uribe H (2012). “Pituitary tumors in patients with MEN1 syndrome”. Clinics (Sao Paulo). 67 Suppl 1: 43–8. PMC 3328811. PMID 22584705.
- ↑ Donnelly, Martin J.; Daly, Carmel A.; Briggs, Robert J. S. (2007). “MR imaging features of an intracochlear acoustic schwannoma”. The Journal of Laryngology & Otology. 108 (12). doi:10.1017/S0022215100129056. ISSN 0022-2151.
- ↑ Feany MB, Anthony DC, Fletcher CD (May 1998). “Nerve sheath tumours with hybrid features of neurofibroma and schwannoma: a conceptual challenge”. Histopathology. 32 (5): 405–10. PMID 9639114.
- ↑ Chen H, Xue L, Wang H, Wang Z, Wu H (July 2017). “Differential NF2 Gene Status in Sporadic Vestibular Schwannomas and its Prognostic Impact on Tumour Growth Patterns”. Sci Rep. 7 (1): 5470. doi:10.1038/s41598-017-05769-0. PMID 28710469.
- ↑ Hardell, Lennart; Hansson Mild, Kjell; Sandström, Monica; Carlberg, Michael; Hallquist, Arne; Påhlson, Anneli (2003). “Vestibular Schwannoma, Tinnitus and Cellular Telephones”. Neuroepidemiology. 22 (2): 124–129. doi:10.1159/000068745. ISSN 0251-5350.
- ↑ Chinn RJ, Wilkinson ID, Hall-Craggs MA, Paley MN, Miller RF, Kendall BE, Newman SP, Harrison MJ (December 1995). “Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy”. Radiology. 197 (3): 649–54. doi:10.1148/radiology.197.3.7480733. PMID 7480733.
- ↑ Paulus, Werner (1999). “Classification, Pathogenesis and Molecular Pathology of Primary CNS Lymphomas”. Journal of Neuro-Oncology. 43 (3): 203–208. doi:10.1023/A:1006242116122. ISSN 0167-594X.
- ↑ Sathornsumetee S, Rich JN, Reardon DA (November 2007). “Diagnosis and treatment of high-grade astrocytoma”. Neurol Clin. 25 (4): 1111–39, x. doi:10.1016/j.ncl.2007.07.004. PMID 17964028.
- ↑ Pedersen CL, Romner B (January 2013). “Current treatment of low grade astrocytoma: a review”. Clin Neurol Neurosurg. 115 (1): 1–8. doi:10.1016/j.clineuro.2012.07.002. PMID 22819718.
- ↑ Mattle, Heinrich (2017). Fundamentals of neurology : an illustrated guide. Stuttgart New York: Thieme. ISBN 9783131364524.
- ↑ Dorwart, R H; Wara, W M; Norman, D; Levin, V A (1981). “Complete myelographic evaluation of spinal metastases from medulloblastoma”. Radiology. 139 (2): 403–408. doi:10.1148/radiology.139.2.7220886. ISSN 0033-8419.
- ↑ Fruehwald-Pallamar, Julia; Puchner, Stefan B.; Rossi, Andrea; Garre, Maria L.; Cama, Armando; Koelblinger, Claus; Osborn, Anne G.; Thurnher, Majda M. (2011). “Magnetic resonance imaging spectrum of medulloblastoma”. Neuroradiology. 53 (6): 387–396. doi:10.1007/s00234-010-0829-8. ISSN 0028-3940.
- ↑ Burger, P. C.; Grahmann, F. C.; Bliestle, A.; Kleihues, P. (1987). “Differentiation in the medulloblastoma”. Acta Neuropathologica. 73 (2): 115–123. doi:10.1007/BF00693776. ISSN 0001-6322.
- ↑ Yuh, E. L.; Barkovich, A. J.; Gupta, N. (2009). “Imaging of ependymomas: MRI and CT”. Child’s Nervous System. 25 (10): 1203–1213. doi:10.1007/s00381-009-0878-7. ISSN 0256-7040.
- ↑ Brunel H, Raybaud C, Peretti-Viton P, Lena G, Girard N, Paz-Paredes A, Levrier O, Farnarier P, Manera L, Choux M (September 2002). “[Craniopharyngioma in children: MRI study of 43 cases]”. Neurochirurgie (in French). 48 (4): 309–18. PMID 12407316.
- ↑ Prabhu, Vikram C.; Brown, Henry G. (2005). “The pathogenesis of craniopharyngiomas”. Child’s Nervous System. 21 (8–9): 622–627. doi:10.1007/s00381-005-1190-9. ISSN 0256-7040.
- ↑ Kennedy HB, Smith RJ (December 1975). “Eye signs in craniopharyngioma”. Br J Ophthalmol. 59 (12): 689–95. PMC 1017436. PMID 766825.
- ↑ Ahmed SR, Shalet SM, Price DA, Pearson D (September 1983). “Human chorionic gonadotrophin secreting pineal germinoma and precocious puberty”. Arch. Dis. Child. 58 (9): 743–5. PMID 6625640.
- ↑ Sano, Keiji (1976). “Pinealoma in Children”. Pediatric Neurosurgery. 2 (1): 67–72. doi:10.1159/000119602. ISSN 1016-2291.
- ↑ Baggenstoss, Archie H. (1939). “PINEALOMAS”. Archives of Neurology And Psychiatry. 41 (6): 1187. doi:10.1001/archneurpsyc.1939.02270180115011. ISSN 0096-6754.
- ↑ Kucharczyk, W; Lemme-Pleghos, L; Uske, A; Brant-Zawadzki, M; Dooms, G; Norman, D (1985). “Intracranial vascular malformations: MR and CT imaging”. Radiology. 156 (2): 383–389. doi:10.1148/radiology.156.2.4011900. ISSN 0033-8419.
- ↑ Fleetwood, Ian G; Steinberg, Gary K (2002). “Arteriovenous malformations”. The Lancet. 359 (9309): 863–873. doi:10.1016/S0140-6736(02)07946-1. ISSN 0140-6736.
- ↑ Chapman, Arlene B.; Rubinstein, David; Hughes, Richard; Stears, John C.; Earnest, Michael P.; Johnson, Ann M.; Gabow, Patricia A.; Kaehny, William D. (1992). “Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease”. New England Journal of Medicine. 327 (13): 916–920. doi:10.1056/NEJM199209243271303. ISSN 0028-4793.
- ↑ Castori M, Voermans NC (October 2014). “Neurological manifestations of Ehlers-Danlos syndrome(s): A review”. Iran J Neurol. 13 (4): 190–208. PMC 4300794. PMID 25632331.
- ↑ Schievink, W. I.; Raissi, S. S.; Maya, M. M.; Velebir, A. (2010). “Screening for intracranial aneurysms in patients with bicuspid aortic valve”. Neurology. 74 (18): 1430–1433. doi:10.1212/WNL.0b013e3181dc1acf. ISSN 0028-3878.
- ↑ Germain DP (May 2017). “Pseudoxanthoma elasticum”. Orphanet J Rare Dis. 12 (1): 85. doi:10.1186/s13023-017-0639-8. PMC 5424392. PMID 28486967.
- ↑ Farahmand M, Farahangiz S, Yadollahi M (October 2013). “Diagnostic Accuracy of Magnetic Resonance Angiography for Detection of Intracranial Aneurysms in Patients with Acute Subarachnoid Hemorrhage; A Comparison to Digital Subtraction Angiography”. Bull Emerg Trauma. 1 (4): 147–51. PMC 4789449. PMID 27162847.
- ↑ Haimes, AB; Zimmerman, RD; Morgello, S; Weingarten, K; Becker, RD; Jennis, R; Deck, MD (1989). “MR imaging of brain abscesses”. American Journal of Roentgenology. 152 (5): 1073–1085. doi:10.2214/ajr.152.5.1073. ISSN 0361-803X.
- ↑ Brouwer, Matthijs C.; Tunkel, Allan R.; McKhann, Guy M.; van de Beek, Diederik (2014). “Brain Abscess”. New England Journal of Medicine. 371 (5): 447–456. doi:10.1056/NEJMra1301635. ISSN 0028-4793.
- ↑ Morgado, Carlos; Ruivo, Nuno (2005). “Imaging meningo-encephalic tuberculosis”. European Journal of Radiology. 55 (2): 188–192. doi:10.1016/j.ejrad.2005.04.017. ISSN 0720-048X.
- ↑ Be NA, Kim KS, Bishai WR, Jain SK (March 2009). “Pathogenesis of central nervous system tuberculosis”. Curr. Mol. Med. 9 (2): 94–9. PMC 4486069. PMID 19275620.
- ↑ Chinn RJ, Wilkinson ID, Hall-Craggs MA, Paley MN, Miller RF, Kendall BE, Newman SP, Harrison MJ (December 1995). “Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy”. Radiology. 197 (3): 649–54. doi:10.1148/radiology.197.3.7480733. PMID 7480733.
- ↑ Helton KJ, Maron G, Mamcarz E, Leventaki V, Patay Z, Sadighi Z (November 2016). “Unusual magnetic resonance imaging presentation of post-BMT cerebral toxoplasmosis masquerading as meningoencephalitis and ventriculitis”. Bone Marrow Transplant. 51 (11): 1533–1536. doi:10.1038/bmt.2016.168. PMID 27348541.
- ↑ Taslakian B, Darwish H (September 2016). “Intracranial hydatid cyst: imaging findings of a rare disease”. BMJ Case Rep. 2016. doi:10.1136/bcr-2016-216570. PMC 5030532. PMID 27620198.
- ↑ McCarthy M, Rosengart A, Schuetz AN, Kontoyiannis DP, Walsh TJ (July 2014). “Mold infections of the central nervous system”. N. Engl. J. Med. 371 (2): 150–60. doi:10.1056/NEJMra1216008. PMC 4840461. PMID 25006721.
- ↑ McCarthy M, Rosengart A, Schuetz AN, Kontoyiannis DP, Walsh TJ (July 2014). “Mold infections of the central nervous system”. N. Engl. J. Med. 371 (2): 150–60. doi:10.1056/NEJMra1216008. PMC 4840461. PMID 25006721.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
The prevalence of Arnold Chiari malformation is unknown since most of the cases are accidentally found. The mortality rate of Arnold Chiari malformation depends on the subtype but type 3 has the highest mortality rate as a result of respiratory failure in infancy. Arnold Chiari malformation commonly affects adolescence and adulthood, but also has been seen in younger children. There is no racial predilection to Arnold Chiari malformation.
Epidemiology and Demographics
Prevalence
- The prevalence of Arnold Chiari malformation is unknown since most of the cases are accidentally found.[1]
- It is believed that approximate prevalence is 0.1 to 0.5 percent worldwide.
Mortality rate
- The mortality rate of Arnold Chiari malformation depends on the subtype.
- Type 3 has the highest mortality rate as a result of respiratory failure in infancy.
Age
- Arnold Chiari malformation commonly affects adolescence and adulthood, but also has been seen in younger children.
Race
- There is no racial predilection to Arnold Chiari malformation.
- Arnold Chiari malformation usually presents with back pain in whites and lower extremity weakness in African-Americans.
Gender
- Women are more commonly affected by Arnold Chiari malformation than men. The women to men ratio is approximately 3 to 1.
References
- ↑ Schijman E (May 2004). “History, anatomic forms, and pathogenesis of Chiari I malformations”. Childs Nerv Syst. 20 (5): 323–8. doi:10.1007/s00381-003-0878-y. PMID 14762679.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Common risk factors in the development of Arnold-Chiari malformation include lumbar-peritoneal shunt and multiple lumbar puncture.
Risk Factors
Common Risk Factors
- Common risk factors in the development of Arnold-Chiari malformation include:[1][2]
- Lumbar-peritoneal shunt
- Multiple lumbar puncture
Less Common Risk Factors
- Less common risk factors in the development of Arnold-Chiari malformation include:[3][4][5]
- Vitamin D-resistant rickets
- Craniosynostosis
- Osteopetrosis
References
- ↑ Payner, Troy D.; Prenger, Erin; Berger, Thomas S.; Crone, Kerry R. (1994). “Acquired Chiari Malformations”. Neurosurgery. 34 (3): 429–434. doi:10.1227/00006123-199403000-00007. ISSN 0148-396X.
- ↑ Payner, Troy D.; Prenger, Erin; Berger, Thomas S.; Crone, Kerry R. (1994). “Acquired Chiari Malformations”. Neurosurgery. 34 (3): 429–434. doi:10.1227/00006123-199403000-00007. ISSN 0148-396X.
- ↑ Kuether, Todd A.; Piatt, Joseph H. (1998). “Chiari Malformation Associated with Vitamin D-resistant Rickets: Case Report”. Neurosurgery. 42 (5): 1168–1171. doi:10.1097/00006123-199805000-00134. ISSN 0148-396X.
- ↑ Cinalli, Giuseppe; Spennato, Pietro; Sainte-Rose, Christian; Arnaud, Eric; Aliberti, Ferdinando; Brunelle, Francis; Cianciulli, Emilio; Renier, Dominique (2005). “Chiari malformation in craniosynostosis”. Child’s Nervous System. 21 (10): 889–901. doi:10.1007/s00381-004-1115-z. ISSN 0256-7040.
- ↑ Dlouhy, Brian J.; Menezes, Arnold H. (2011). “Osteopetrosis with Chiari I malformation: presentation and surgical management”. Journal of Neurosurgery: Pediatrics. 7 (4): 369–374. doi:10.3171/2011.1.PEDS10353. ISSN 1933-0707.
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
- The symptoms of (disease name) typically develop ___ years after exposure to ___.
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
- Common complications of [disease name] include:
- [Complication 1]
- [Complication 2]
- [Complication 3]
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [–]%.
- Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
References
Diagnosis
Diagnosis
Diagnostic Study of Choice |History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
